My gut feeling is that a new CMO may be on the way- Now, someone who would take the job might just know a little more than you or me (gfp, I mean you) Again the world is awash in future drug revenue needs and the capital to provide capital to deliver, develop them or buy them. So it's the reverse mentation of the crummy news, versus a $3 when this board felt collectively a liftoff to $5 or higher was in the immediate offing- I am not saying the ADHD news was good, but the science remains powerful and valued at umm......about $35 million dollars-we won't need to calculate fully diluted shares till she crosses $2.50-3....don't a bunch of guys at Goldman Sachs make that? Could a real benefactor emerge and make the bad dream go away? Could we have a plan B you and I don't know about? Why was Stoll insistent about waiting for some of the pilot studies be done before any ADHD deal signed? Is there something else in the offing? A just in case scenario? I enjoy your posts gfp, but your mood swings ( and I understand this hit you hard , it hit me too) are like the old Wide World Of Sports ads......Please understand I am not being critical of you personally----just that you hate the name when it is down and love it up. One day things will be better- I'll sell some then, and for the record I think we will have a new CMO with an impressive resume and I know nothing , just a hunch.